AVIR - CIK 0001593899
The table below shows Atea Pharmaceuticals, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $95.71M | $64.70M | $143.82M | $188.46M | $764.38M | $850.12M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $310.99M |
| $462.36M |
| $590.46M |
| $660.92M |
| $772.40M |
| $863.48M |
| Property, plant & equipment | $457.00K | $873.00K | $1.29M | $1.71M | $23.00K | $48.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $315.22M | $464.67M | $594.97M | $666.71M | $772.89M | $863.63M |
| Accounts payable | $12.95M | $4.46M | $4.25M | $2.55M | $4.53M | $60.00K |
| Total current liabilities | $39.78M | $18.60M | $32.38M | $18.48M | $56.88M | $315.80M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $39.78M | $25.80M | $39.78M | $26.14M | $62.81M | $315.83M |
| Retained earnings | -$522.57M | -$364.22M | -$195.84M | -$59.88M | $56.03M | -$65.16M |
| Total equity | $275.43M | $438.87M | $555.19M | $640.57M | $710.08M | $547.80M |